Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Data Dynamo's Dilemma | Definitive Healthcare faces challenges in sales and metrics, prompting leadership changes and a strategic overhaul to maintain its position in healthcare analytics |
Financial Crossroads | Despite recent stock decline, analysts set price targets between $4-$7. EPS estimates: 0.33 (FY1) and 0.35 (FY2), with an impressive 85% gross profit margin |
Sector Strength Amidst Turmoil | High EBITDA margin and diverse client base buffer against risks. Growing demand in bio-pharma R&D spending signals potential for future expansion |
Navigating Future Waters | Explore DH's strategies to leverage AI, expand internationally, and capitalize on increasing healthcare data needs while addressing subscription churn risks |
Metrics to compare | DH | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipDHPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.8x | −1.9x | −0.5x | |
PEG Ratio | 0.01 | −0.01 | 0.00 | |
Price/Book | 1.8x | 0.7x | 2.6x | |
Price / LTM Sales | 2.3x | 1.4x | 3.3x | |
Upside (Analyst Target) | 4.2% | 26.6% | 43.5% | |
Fair Value Upside | Unlock | 11.6% | 6.3% | Unlock |